Lung cancer remains the leading cause of cancer death worldwide. According to the World Health Organization, lung cancer was responsible for 1.8 million deaths — 18% of cancer deaths — in 2020 alone.
Bill Jarvis, our Senior Process Engineer, Sr. Associate, shares, "Those of us at CRB feel like we have grown up with the RNA industry; we’ve watched this technology space go from niche to one of the hottest areas of biopharma development."
In our latest Horizons Report, we found that embracing sustainable change is no longer negotiable as 97% of life sciences companies report having committed to sustainability metrics – with three key factors driving these commitments.
COVID-19 inflicted tremendous suffering in 2021, taking almost 3.5 million lives this year, more than died from HIV/AIDS, tuberculosis and malaria combined last year.
According to the Association of American Medical Colleges, only 7% of medical students, 6% of medical school graduates, and only 5% of physicians are Black.
In the next two decades, the global population over age 65 is expected to increase exponentially. With this aging population, we will see a rise in the development of chronic conditions like cardiovascular diseases and diabetes.
We’re incredibly proud of how our own healthcare heroes have worked tirelessly in the fight against COVID-19. Messages, like this one from Gov. Ralph Northam of Virginia, highlight the impact that we’re making.
Merck and Ridgeback Biotherapeutics announced the U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for molnupiravir, an investigational oral antiviral (MK-4482, EIDD-2801).
At Whirlpool Corporation, we have a history of advances in sustainability founded on a simple principle: "Do the right things, the right ways. Always...
Advancing women and minority-owned small businesses and entrepreneurs around the world. Small to mid-sized businesses power their local economies and...
